MOLOGEN Lifescience AG (Frankfurt:U1DA.F)

Germany · Delayed Price · Currency is EUR

2.80+0.00 (+0.00%)

Market Cap	3.86M+16.7%
Revenue (ttm)	45.12K
Net Income	-85.29K
EPS	-1.40
Shares Out	1.38M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Open	2.80
Previous Close	2.80
Day's Range	2.80 - 2.80
52-Week Range	1.80 - 4.50
Beta	0.50
Analysts	none
Price Target	n/a
Earnings Date	n/a

+0.00% (1D)

No price history available.

Full Chart

Alerts Compare

Insider Score

––Not scored

U1DA.F Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

See stocks that are scored

About U1DA.F

MOLOGEN Lifescience AG operates as an investment company in Germany. It focuses on investments in seed and series A and B company phases, as well as in investment phases in the fields of fintech, blockchain, and related technologies. The company was formerly known as Finchain Capital Partners AG and changed its name to MOLOGEN Lifescience AG in April 2026. MOLOGEN Lifescience AG was founded in 2015 and is headquartered in Düsseldorf, Germany.

Address

Königsallee 27, Düsseldorf, 40212, Germany

Market Cap

4 million

Employees

—

Industrial Classification

Asset Management

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying

Sold

Bought

$174.28K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day

+0.00%

5 Days

+0.00%

1 Month

+0.00%

6 Months

+0.00%

1 Year

+16.67%

$U1DA.F stock is featured in our Insider Trades datasets.

→ All Stock Lists

Whale Activity →

Recently reported changes in U1DA.F holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by U1DA.F's directors and management

Source: SEC EDGAR (Form 4)

Corporate Lobbying

U1DA.F Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New U1DA.F patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to U1DA.F from public contracts

Source: USAspending.gov

U1DA.F Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for U1DA.F yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from U1DA.F’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys

Sells

Buy Value

$174.28K

Distinct Buyers

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.